Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.
Lisa PaganC YfantiR RijneveldM ToddP JongsteJ J FeijenE S KlaassenJ N Bouwes BavinckL StruijkM N C de KoningL PrestegardenTessa Niemeyer van der KolkM I E van PoelgeestR RissmannPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)